天弘中证医药100A(001550)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-119,770,256.71 |
99,984,152.98 |
75,411,919.41 |
-140,884,313.10 |
| 利息合计 |
532,818.05 |
1,184,645.54 |
611,958.76 |
1,354,933.01 |
| 其中:存款利息收入 |
532,818.05 |
1,184,645.54 |
611,958.76 |
1,354,933.01 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-24,530,810.83 |
-3,149,139.30 |
-2,054,176.29 |
-91,916,150.20 |
| 其中:股票投资收益 |
-39,703,470.62 |
-27,310,746.74 |
-17,248,686.44 |
-121,224,261.08 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
9,307.33 |
2,272.33 |
5,210.48 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
15,172,659.79 |
24,152,300.11 |
15,192,237.82 |
27,469,553.70 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-95,841,952.59 |
101,866,469.28 |
76,814,296.65 |
-50,651,326.47 |
| 其他收入 |
69,688.66 |
82,177.46 |
39,840.29 |
328,230.56 |
| 费用 |
4,712,608.90 |
10,553,554.16 |
5,380,966.62 |
10,992,303.69 |
| 管理人报酬 |
3,314,671.23 |
7,371,662.97 |
3,724,162.05 |
7,437,035.20 |
| 基金托管费 |
662,934.24 |
1,474,332.51 |
744,832.35 |
1,487,407.10 |
| 销售服务费 |
644,255.46 |
1,459,550.92 |
756,216.49 |
1,572,755.37 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
90,747.97 |
248,007.76 |
155,755.73 |
480,481.49 |
| 利润总额 |
-124,482,865.61 |
89,430,598.82 |
70,030,952.79 |
-151,876,616.79 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年